Skip to content

NXTLAB

Active
Private limited companyfounded 2024active for 2 yearsDeltalaan 1, 8800 Roeselare, Belgium83 active companies are registered at this addressKBO/BCE: BE 1006.873.757
Summary

NXTLAB has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1,389 and a net result of €114,009. Its solvency ranks better than 15% of 605 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Activity
Research and development on biotechnology
NACE 72101
1 site
Size
€119,190total assets 2025
Equity
€1,389
Profit
€114,009
Turnover not published (micro format)
Financial health
88 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Structure
Accounts 39 days early0 of 1 deed read
Why 88raises riskEquity €1,389 (1.2% of total assets)lowers riskSector: Scientific research and development (NACE 72)Liquidity: current ratio 1.01, cash €82,501Size: total assets €119,190Show the evidence

Checked score

Score 2025
88 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 46% of its sector peers (NACE 72, micro)
Financial strength · tick = 2024
Average
Solvency 26-5
equity 1.2% of total assets
Liquidity 50=
short-term debt 98.8% · cash 69.2%
Profitability 100=
return on assets 95.7%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (937 companies, NACE 72, micro)
Last 24 months 04-2025: 0.7% 05-2025: 0.7%● unchanged vs 04-2025 06-2025: 0.7%● unchanged vs 05-2025 07-2025: 0.8%▲ +0.1 percentage points vs 06-2025highest value 08-2025: 0.2%▼ -0.6 percentage points vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.3%▲ +0.1 percentage points vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.4%▲ +0.1 percentage points vs 07-2026 09-2026: 0.5%▲ +0.1 percentage points vs 08-2026 10-2026: 0.2%▼ -0.3 percentage points vs 09-2026lowest value
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro): better than 18% on solvency, 28% on liquidity, 90% on profitability and 50% on growth.

The bankruptcy probability was computed on 11-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Seven signals.
lowers riskraises riskneutral
lowers risk · Sector: Scientific research and development (NACE 72)
KBO
lowers risk · Liquidity: current ratio 1.01, cash €82,501
NBB · annual accounts
raises risk · Equity €1,389 (1.2% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €119,190
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 605 sector peers (2025).
NBB · sector comparison
Position among 605 sector peers
Solvency
better than 15%
← weakest strongest →
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-06-2026, 39 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
39 days early
2024
17 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 28 days before the deadline; the sector median (NACE 72) for financial year 2024 is 13 days before the deadline, and 33% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
12-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2024.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: Result rose in 2025from €21,181 to €114,009 ▲ 438% View
  • Caution: Among the weakest 15% on equitysector median €113,303 · 606 companies €1,389 View
  • Total assets 20252 financial years filed €119,190 View

By topic

Financials

Financial year
2025
Total assets
€119,190
Profit
€114,009
Solvency
1.2%
Total assets▲ 388%
Net result
20242025
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
Research and development on biotechnologyNACE 72101
Founded
07-03-2024
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.